Fish Oil Phospholipid Composition for Joint Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis and rheumatoid arthritis, such as krill oil and other active constituents, have limitations in effectively alleviating joint pain and symptoms, prompting the need for alternative therapeutic compositions that offer more synergistic benefits.
Innovation Solution
A therapeutic composition combining fish oil with fish oil-derived, choline-based, phospholipid-bound fatty acids containing EPA and DHA, along with astaxanthin and low molecular weight polymers of hyaluronic acid or sodium hyaluronate, administered in an oral dosage form, which can include additional active constituents like glucosamine sulfate or omega-3 fatty acid-rich oils, to treat osteoarthritis and rheumatoid arthritis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional treatments like krill oil are used to alleviate joint pain, then some therapeutic effect is achieved, but the effectiveness is limited and symptoms are not sufficiently alleviated
Solution Approach 1:
The patent combines multiple active constituents (fish oil, phospholipid-bound fatty acids, astaxanthin, hyaluronic acid, glucosamine sulfate, omega-3 fatty acids) into a composite therapeutic composition. This composite approach creates synergistic effects where the combination of ingredients provides greater therapeutic effectiveness for alleviating joint pain and symptoms of osteoarthritis and rheumatoid arthritis compared to traditional single-ingredient treatments like krill oil alone.
2Reliability
If fish oil and phospholipid-bound fatty acids are combined with multiple active constituents, then synergistic therapeutic effects are enhanced, but the composition complexity increases
Solution Approach 1:
The patent merges multiple active constituents into a single integrated therapeutic composition. By combining fish oil, phospholipid-bound fatty acids, astaxanthin, hyaluronic acid, glucosamine sulfate, and omega-3 fatty acids into one formulation, the patent achieves synergistic therapeutic effects while providing a convenient single-dose treatment that simplifies administration despite the complexity of the composition itself.
Data Source
AI summary
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA either alone or in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.